Journal
MOLECULES
Volume 25, Issue 17, Pages -Publisher
MDPI
DOI: 10.3390/molecules25173915
Keywords
4-amino-2; 3-polymethylene-quinoline; acetylcholinesterase (AChE); ADMET; Alzheimer's disease (AD); butyrylcholinesterase (BChE); molecular docking; p-tolylsulfonamide
Funding
- Russian Foundation for Basic Research [19-53-26016_a]
- IPAC RAS State Targets Project [0090-2019-0005]
Ask authors/readers for more resources
New hybrid compounds of 4-amino-2,3-polymethylene-quinoline containing different sizes of the aliphatic ring and linked top-tolylsulfonamide with alkylene spacers of increasing length were synthesized as potential drugs for treatment of Alzheimer's disease (AD). All compounds were potent inhibitors of acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) with selectivity toward BChE. The lead compound 4-methyl-N-(5-(1,2,3,4-tetrahydro-acridin-9-ylamino)-pentyl)-benzenesulfonamide (7h) exhibited an IC50(AChE) = 0.131 +/- 0.01 mu M (five times more potent than tacrine), IC50(BChE) = 0.0680 +/- 0.0014 mu M, and 17.5 +/- 1.5% propidium displacement at 20 mu M. The compounds possessed low activity against carboxylesterase, indicating a likely absence of unwanted drug-drug interactions in clinical use. Kinetics studies were consistent with mixed-type reversible inhibition of both cholinesterases. Molecular docking demonstrated dual binding sites of the conjugates in AChE and clarified the differences in the structure-activity relationships for AChE and BChE inhibition. The conjugates could bind to the AChE peripheral anionic site and displace propidium, indicating their potential to block AChE-induced beta-amyloid aggregation, thereby exerting a disease-modifying effect. All compounds demonstrated low antioxidant activity. Computational ADMET profiles predicted that all compounds would have good intestinal absorption, medium blood-brain barrier permeability, and medium cardiac toxicity risk. Overall, the results indicate that the novel conjugates show promise for further development and optimization as multitarget anti-AD agents.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available